Xinan Shi

In Silico Identification and In Vitro and In Vivo Validation of Anti-Psychotic Drug Fluspirilene as a Potential CDK2 Inhibitor and a Candidate Anti-Cancer Drug

Xinan Shi, Hongjian Li, Hong Yao et al. · PLoS ONE · 2015 · 81 citations · Full text

Chemoprevention Strategy, Anti-psychotic Drug Fluspirilene, Pathology +17

Adapalene inhibits the activity of cyclin-dependent kinase 2 in colorectal carcinoma

Xinan Shi, Hongjian Li, Hong Yao et al. · Molecular Medicine Reports · 2015 · 59 citations · Full text

Chemoprevention Strategy, Cell Cycle, Cancer Biology +17

Discovery of a New CDK4/6 and PI3K/AKT Multiple Kinase Inhibitor Aminoquinol for the Treatment of Hepatocellular Carcinoma

Zhong-Kun Xia, Wei Wang, Jian-Ge Qiu et al. · Frontiers in Pharmacology · 2021 · 37 citations · Full text

Discovery of rafoxanide as a dual CDK4/6 inhibitor for the treatment of skin cancer

Xinan Shi, Hongjian Li, Anhua Shi et al. · Oncology Reports · 2018 · 28 citations · Full text

The antipsychotic agent flupentixol is a new PI3K inhibitor and potential anticancer drug for lung cancer

Chao Dong, Yin Chen, Hongjian Li et al. · International Journal of Biological Sciences · 2019 · 25 citations · Full text